Menu
▾
▴
openflow-dev
You can subscribe to this list here.
| 2000 |
Jan
|
Feb
(9) |
Mar
(2) |
Apr
(1) |
May
|
Jun
(2) |
Jul
|
Aug
|
Sep
(1) |
Oct
|
Nov
|
Dec
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2001 |
Jan
|
Feb
(1) |
Mar
(28) |
Apr
|
May
|
Jun
|
Jul
(3) |
Aug
(2) |
Sep
(27) |
Oct
(31) |
Nov
(7) |
Dec
(23) |
| 2002 |
Jan
(22) |
Feb
(29) |
Mar
(50) |
Apr
(1) |
May
|
Jun
(6) |
Jul
(3) |
Aug
(5) |
Sep
(27) |
Oct
(39) |
Nov
(27) |
Dec
(17) |
| 2003 |
Jan
(25) |
Feb
(33) |
Mar
(15) |
Apr
(38) |
May
(8) |
Jun
(17) |
Jul
(5) |
Aug
(3) |
Sep
(6) |
Oct
(11) |
Nov
(5) |
Dec
|
| 2004 |
Jan
(10) |
Feb
(6) |
Mar
(2) |
Apr
|
May
(7) |
Jun
(1) |
Jul
(1) |
Aug
(1) |
Sep
|
Oct
|
Nov
(1) |
Dec
(2) |
| 2005 |
Jan
|
Feb
(3) |
Mar
(5) |
Apr
|
May
(6) |
Jun
(12) |
Jul
|
Aug
(2) |
Sep
(3) |
Oct
(2) |
Nov
|
Dec
|
| 2006 |
Jan
|
Feb
|
Mar
|
Apr
(4) |
May
(9) |
Jun
(5) |
Jul
(1) |
Aug
(16) |
Sep
(1) |
Oct
(6) |
Nov
(2) |
Dec
(2) |
| 2007 |
Jan
(17) |
Feb
(16) |
Mar
|
Apr
|
May
|
Jun
|
Jul
|
Aug
|
Sep
(6) |
Oct
(1) |
Nov
|
Dec
|
| 2008 |
Jan
|
Feb
|
Mar
|
Apr
(3) |
May
|
Jun
|
Jul
|
Aug
|
Sep
|
Oct
|
Nov
|
Dec
(8) |
| 2009 |
Jan
(4) |
Feb
(3) |
Mar
(4) |
Apr
(7) |
May
(2) |
Jun
(11) |
Jul
(1) |
Aug
(15) |
Sep
(13) |
Oct
(27) |
Nov
(21) |
Dec
(10) |
| 2010 |
Jan
(7) |
Feb
(5) |
Mar
(13) |
Apr
(31) |
May
(37) |
Jun
(17) |
Jul
(22) |
Aug
(20) |
Sep
(22) |
Oct
(19) |
Nov
(18) |
Dec
(15) |
| 2011 |
Jan
(16) |
Feb
(12) |
Mar
(8) |
Apr
(3) |
May
(1) |
Jun
(5) |
Jul
(3) |
Aug
(7) |
Sep
(7) |
Oct
(7) |
Nov
(3) |
Dec
(4) |
| 2012 |
Jan
(3) |
Feb
(2) |
Mar
(2) |
Apr
(6) |
May
(6) |
Jun
(2) |
Jul
(4) |
Aug
(3) |
Sep
(2) |
Oct
(4) |
Nov
(8) |
Dec
(13) |
| 2013 |
Jan
(2) |
Feb
(5) |
Mar
(13) |
Apr
(6) |
May
(6) |
Jun
(3) |
Jul
(6) |
Aug
(7) |
Sep
(6) |
Oct
(3) |
Nov
|
Dec
(1) |
| 2014 |
Jan
|
Feb
(2) |
Mar
(6) |
Apr
(6) |
May
(5) |
Jun
(7) |
Jul
(4) |
Aug
(1) |
Sep
(2) |
Oct
(15) |
Nov
(8) |
Dec
(3) |
| 2015 |
Jan
(6) |
Feb
(2) |
Mar
(10) |
Apr
(2) |
May
(3) |
Jun
(1) |
Jul
(5) |
Aug
(1) |
Sep
(2) |
Oct
(1) |
Nov
(1) |
Dec
(1) |
| 2016 |
Jan
(2) |
Feb
|
Mar
(5) |
Apr
(6) |
May
(5) |
Jun
(5) |
Jul
|
Aug
|
Sep
(2) |
Oct
(3) |
Nov
(2) |
Dec
(6) |
| 2017 |
Jan
(2) |
Feb
(5) |
Mar
(3) |
Apr
|
May
(1) |
Jun
(3) |
Jul
(4) |
Aug
|
Sep
|
Oct
|
Nov
|
Dec
|
|
From: Sandy Nguyen<san...@vg...> - 2010-11-02 01:34:26
|
Pharmacovigilance and Other Pharma Regulatory Developments 2010-2020 Report |
|
From: Sandy Nguyen<san...@vg...> - 2010-10-28 09:38:43
|
Chinese Pharmaceutical Market 2010-2025 Report |
|
From: Sandy Nguyen<san...@vg...> - 2010-10-26 08:07:51
|
Medical Devices: Industry and Market Prospects 2010-2025 Report |
|
From: Sandy Nguyen<san...@vg...> - 2010-10-23 00:13:20
|
Anti-Counterfeiting Americas Conference 2010 |
|
From: Stefan K. | ASDReports.c. <Lif...@AS...> - 2010-10-21 19:57:48
|
[1]ASDReports Molecular Diagnostics Markets * This TriMark Publications report describes the specific market segment of the in vitro diagnostics market known as molecular diagnostics and includes all of the generally accepted clinical analytical activities in use today. It examines the prevalent clinical-measurement devices, as well as their reagents and supplies as utilized in hospitals, clinics, large reference laboratories and doctors offices. Diagnostic tests marketed primarily as over-the-counter are generally not included in this report, although there is inevitably some overlap. * The main objectives of this analysis are: * 1) identifying viable technology drivers through a comprehensive look at platform technologies for molecular diagnostics, including probe-based nucleic acid assays, microarrays and sequencing; * 2) obtaining a complete understanding of the chief molecular diagnostics tests--i.e., predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic--from their basic principles to their applications; * 3) discovering feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas and by focusing on expanding markets, such as communicable diseases, cardiology and oncology; and * 4) focusing on global industry development through an in-depth analysis of the major world markets for molecular diagnostics, including growth forecasts. + + >> [2]Click here for more details on this report More Life Science Diagnostics market reports are available on [3]ASDReports.com/Diagnostics References 1. http://www.asdreports.com/ 2. http://www.asdreports.com/shopexd.asp?id=948&utm_source=Energy_Reports&utm_medium=email&utm_campaign=RP_LifeScience 3. http://www.asdreports.com/shopdisplayproducts.asp?id=161&utm_source=Energy_Reports&utm_medium=email&utm_campaign=RP_LifeScience This message was sent by: Stefan Koopman, Veemkade 326, Amsterdam, NH 1019HD, Netherlands Manage your subscription: http://app.icontact.com/icp/mmail-mprofile.pl?r=14971947&l=8066&s=7Z8S&m=67174&c=768060 |
|
From: Sandy Nguyen<san...@vg...> - 2010-10-20 08:43:00
|
Drug Delivery Technologies: Commercial Prospects 2010-2025 Report |
|
From: Sandy Nguyen<san...@vg...> - 2010-10-18 06:08:00
|
3rd Pre-filled Syringes Conference 2010 |
|
From: Sandy Nguyen<san...@vg...> - 2010-10-14 00:10:14
|
Vaccines Manufacturing Technology and Services: Commercial Prospects 2010-2025 Report |
|
From: Sandy Nguyen<san...@vg...> - 2010-10-12 00:15:00
|
World Diabetes Market Analysis 2010-2025 Report |
|
From: Sandy Nguyen<san...@vg...> - 2010-10-06 11:10:24
|
Statins: The World Market 2010-2025 Report |
|
From: Sandy Nguyen<san...@vg...> - 2010-10-04 09:06:33
|
Dermatological Advances Conference 2010 |
|
From: Erika P. <efc...@ev...> - 2010-10-01 09:03:35
|
This is the text-only body |
|
From: Mr et M. M. <may...@li...> - 2010-09-28 13:35:06
|
Bonjour, Fasse à cette cherté de la vie, ma femme et moi octroyons des prêt à tous particuliers intéressés, Si vous êtes intéressés envoyez nous un mail en nous précisant le montant que vous souhaitez avoir comme prêt et toutes les informations si dessous. Notre Taux dâintérêt 3% Nom: Prénoms: Date de naissance et lieu: Objet du prêt: Montant de prêt: Profession: Adresse: Pays: Tel Mobile: En attente de vous lire veillez agrées mos salutations les plus distinguées Contact : may...@li... Plaisantins sâabstenir !!!!! Plaisantins sâabstenir !!!!! Mr et Mme MAY |
|
From: Stefan - ASDReports.c. <St...@AS...> - 2010-09-27 16:24:59
|
Clinical laboratory analysis for in vitro diagnostic (IVD) testing is one of the most important sectors of medical care. By all accounts, it is very mature, large market employing over 100,000 laboratory workers, and spawning an industry for reagents and instruments comprised of thousands of companies worldwide. The term clinical laboratory analysis usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations. [1]>> Click here to find more details on this new market analysis Find more Life Science reports on [2]ASDReports.com Warm Regards, Stefan Koopman ASDReports.com References 1. http://www.asdreports.com/shopexd.asp?id=926&utm_source=LifeScience_Reports&utm_medium=email&utm_campaign=RP_LifeScience-Trimark 2. http://www.asdreports.com/shopdisplaycategories.asp?id=96&utm_source=LifeScience_Reports&utm_medium=email&utm_campaign=RP_LifeScience-gen This message was sent by: Stefan Koopman, Veemkade 326, Amsterdam, NH 1019HD, Netherlands Manage your subscription: http://app.icontact.com/icp/mmail-mprofile.pl?r=14971947&l=8066&s=7Z8S&m=52214&c=768060 Forward this message: http://app.icontact.com/icp/core/message/forward?m=52214&s=14971947&c=7Z8S&cid=768060 |
|
From: Sandy Nguyen<san...@vg...> - 2010-09-27 12:18:43
|
Biobanking Americas Conference 2010 |
|
From: Stefan - ASDReports.c. <St...@AS...> - 2010-09-24 09:29:24
|
Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than 300 new medicines for cancer, some of which are in development for more than one type of the disease, for a total of more than 500 ongoing R&D projects. [1]>> Click here to find more details on this new market analysis Find more Life Science reports on [2]ASDReports.com Warm Regards, Stefan Koopman ASDReports.com References 1. http://www.asdreports.com/shopexd.asp?id=919&utm_source=LifeScience_Reports&utm_medium=email&utm_campaign=RP_LifeScience-Cancer 2. http://www.asdreports.com/shopdisplaycategories.asp?id=96&utm_source=LifeScience_Reports&utm_medium=email&utm_campaign=RP_LifeScience-gen This message was sent by: Stefan Koopman, Veemkade 326, Amsterdam, NH 1019HD, Netherlands Manage your subscription: http://app.icontact.com/icp/mmail-mprofile.pl?r=14971947&l=8066&s=7Z8S&m=50257&c=768060 Forward this message: http://app.icontact.com/icp/core/message/forward?m=50257&s=14971947&c=7Z8S&cid=768060 |
|
From: Sandy Nguyen<san...@vg...> - 2010-09-21 11:55:07
|
Therapeutic Monoclonal Antibodies: World Market 2010-2025 REPORT |
|
From: Sandy Nguyen<san...@vg...> - 2010-09-18 12:18:11
|
4th Annual Stability Testing Conference 2010 |
|
From: ASDReports-LifeScience <ASD...@ma...> - 2010-09-16 16:44:48
|
The Clinical Trials: World Market 2010-2025 report is released, especially for your company this report provides valuable information. The market for clinical trial services has been expanding rapidly, with impressive revenue growth and expansion of the sector in recent years. Our new study shows how that sector will develop from 2010 onwards, with benefits to the pharma industry and clinical service providers. Clinical research organisations (CROs) are playing increasingly important roles in drug development worldwide, from conducting phase I trials to post-marketing studies. Ageing populations, increasing prevalence of chronic diseases, growing demand for improved therapies and high growth of the pharmaceutical and biotechnology markets worldwide are driving the clinical trials sector and market. The globalisation of development programmes and the increasing complexity of trials - with regulatory developments - are heightening the need for larger trials and greater numbers of trials. Many pharma companies are outsourcing clinical trials to gain cost savings/efficiencies, greater flexibility and specialist expertise. That trend will continue from 2010 onwards, our new study - Clinical Trials: World Market 2010-2025 - reveals. The emerging clinical trial destinations, including CEE countries, India and China, are achieving double-digit growth, our analyses show. Our new report considers perspectives of sponsors and CROs for clinical trial outsourcing/off-shoring. We analyse the sectors strengths, weaknesses and financial prospects from 2010 to 2025 through quantitative and qualitative analyses. This report provides hard-to-find data on the current and future values of clinical trial spending and the CRO market, worldwide and regionally. We address global questions, such as: what proportion of the sector will be held by contract research organisations in future years? Our report also addresses regional questions. For example, how will Indias share of global spending change between 2010 and 2025? Will the Central and Eastern European sector expand more rapidly than that of China? Our new report answers questions such as those, providing the information that you need. >> - http://cts.vresp.com/c/?ASDMediaBV/3dfdb6670e/ee839ee72a/de80a5e913/id=4987&utm_source=LifeScience_Reports&utm_medium=email&utm_campaign=RP_4987_Pharma Click here to find the details of this new market research (If you cannot open the link: the report is available on ASDReports.com, just search 'Clinical Trials'.) If you have any questions on this study or other publications please contact me directly. Kind Regards, Stefan Koopman - ASDMedia BV - Amsterdam - Netherlands T +31.20.486.9620 - M +31.646.260.577 - F +31.20.486.0216 - ste...@as... ste...@as... ______________________________________________________________________ Click to view this email in a browser http://hosted.verticalresponse.com/766559/3dfdb6670e/1460514159/ee839ee72a/ If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: http://cts.vresp.com/u?3dfdb6670e/ee839ee72a/mlpftw ______________________________________________________________________ This message was sent by ASDReports-LifeScience using VerticalResponse ASD Media BV Veemkade 326 Amsterdam, Noord-Holland 1019HD Read the VerticalResponse marketing policy: http://www.verticalresponse.com/content/pm_policy.html |
|
From: Sandy Nguyen<san...@vg...> - 2010-09-14 00:18:45
|
Global Vaccines Market 2010-2025 REPORT |
|
From: T. de C. & C. C. <efc...@ev...> - 2010-09-13 10:27:46
|
This is the text-only body |
|
From: Sandy Nguyen<san...@vg...> - 2010-09-11 08:17:15
|
Anti-Counterfeiting Americas Conference 2010 |
|
From: Sandy Nguyen<san...@vg...> - 2010-09-08 17:12:44
|
Global Antivirals Market 2010-2025 REPORT |
|
From: MICHAEL F. <ma...@ae...> - 2010-09-06 22:45:16
|
We offer loans at 3% interest rate (Between 1,000 USD to 100M USD). Get back if interested: We will furnish you with further instructions. Regards, DR. MICHAEL FORERO CHIEF EXECUTIVE OFFICER Contact email: aeo...@gm... |
|
From: Sandy Nguyen<san...@vg...> - 2010-09-06 16:44:20
|
Biobanking for Medical R&D: Technology and Market 2010-2025 REPORT |
453 messages has been excluded from this view by a project administrator.
